Vasagiri Nagarjuna, Kutala Vijay Kumar
Department of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India.
Mol Biol Rep. 2014 Nov;41(11):7705-14. doi: 10.1007/s11033-014-3664-x. Epub 2014 Aug 6.
BCL-2 [B-cell leukemia/lymphoma 2]/adenovirus E1B 19KD interacting protein 3 (BNIP3) is an atypical BH3 domain only containing member of Bcl2 family of proteins. BNIP3 is known to be involved in various cellular processes depending on the cell type and conditions and also shown to play a role in various disease conditions including myocardial ischemia, autophagy and apoptosis. Though its role in autophagy and its pro-death activity have been reported in various studies, recent findings have shown its contradictory role in the regulation of these cellular processes. The various studies have shown its epigenetic regulation in disease development and progression and also found to be cytoprotective. In this review, we have focused on the structural and functional aspects of BNIP3 in relation to recent advances of its role in autophagy and apoptosis. Also its role of epigenetic regulation of several genes involved in various diseases was also discussed.
BCL-2 [B细胞白血病/淋巴瘤2]/腺病毒E1B 19KD相互作用蛋白3(BNIP3)是一种仅含非典型BH3结构域的Bcl2蛋白家族成员。已知BNIP3根据细胞类型和条件参与各种细胞过程,并且在包括心肌缺血、自噬和凋亡在内的各种疾病状态中也发挥作用。尽管在各种研究中已经报道了它在自噬中的作用及其促死亡活性,但最近的研究结果表明它在这些细胞过程的调节中具有矛盾的作用。各种研究表明它在疾病发生和发展中存在表观遗传调控,并且还发现具有细胞保护作用。在这篇综述中,我们聚焦于BNIP3的结构和功能方面,及其在自噬和凋亡中的作用的最新进展。此外,还讨论了它对参与各种疾病的多个基因的表观遗传调控作用。